Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

Reply to this topic

post Posted: Feb 20 2021, 02:37 PM
  Quote Post

Posts: 8,281
Thanks: 2668

Zelira Therapeutics Limited (ZLD), formerly Zelda Therapeutics Limited, is an Australian based biopharmaceutical company that is focused on developing a range of cannabinoid based formulations for the treatment of a variety of medical conditions.

On 11 October, 2016, Gleneagle Gold Limited (GLN) changed its name and ASX code to Zelda Therapeutics Limited (ZLD).
On 05 December, 2019, Zelda Therapeutics Limited changed its name to Zelira Therapeutics Limited.

Just how many cannabinoid companies are there? This one [today] announced that as part of a strategic consolidation of Zelira's operations, leadership will transfer to the United States based team and, Dr Oludare Odumosu, will now assume the role of global Managing Director of Zelira.

Market cap $90M... probably won't be around on ASX too long

"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne

Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.